Merck & Co., Inc.

MRK · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $298.8B · 75,000 employees
129
SEC Filings
$121.42
Close 2026-04-10
6
Transcripts
75,000
Employees

Business Summary

Merck & Co., Inc. is a global health care company delivering innovative health solutions through prescription medicines, biologic therapies, vaccines, and animal health products. Key products include Keytruda (pembrolizumab) for oncology, Gardasil 9 for HPV prevention, Winrevair for pulmonary arterial hypertension, Januvia for type 2 diabetes, and a broad animal health portfolio covering livestock and companion animals.

Latest Stock Quote

MRK 2026-04-10 $121.42 O:$122.96 H:$123.01 L:$120.95 Vol:9.7M VWAP:$121.5889
origin leaf: b8b4c79981c814c9c48224cb401c1eb542b23875dc7f85dd90f317a86915584f

Next Earnings

expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMRKdiscussed Artificial Intelligence
topic_mentionMRKdiscussed Blockchain & Crypto
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Cybersecurity
topic_mentionMRKdiscussed Blockchain & Crypto
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Supply Chain
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Sovereign & Government
topic_mentionMRKdiscussed Automotive
topic_mentionMRKdiscussed Healthcare & Bio
metricMRK gross marginreported $66.2 percent
metricMRK gross marginreported $74.8 percent
metricMRK gross marginreported $79.7 percent

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310000310158-26-000063EDGAR100K words
2025-02-252024-12-310001628280-25-007732EDGAR
2024-02-262023-12-310001628280-24-006850EDGAR
2023-02-242022-12-310001628280-23-005061EDGAR
2022-02-252021-12-310000310158-22-000003EDGAR
2021-02-252020-12-310000310158-21-000004EDGAR
2020-02-262019-12-310000310158-20-000005EDGAR
2019-02-272018-12-310000310158-19-000014EDGAR
2018-02-272017-12-310000310158-18-000005EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300000310158-25-000059EDGAR42K words
2025-08-052025-06-300000310158-25-000014EDGAR
2025-05-022025-03-310001628280-25-021834EDGAR
2024-11-062024-09-300001628280-24-045689EDGAR
2024-08-052024-06-300001628280-24-034715EDGAR
2024-05-032024-03-310001628280-24-020283EDGAR
2023-11-032023-09-300001628280-23-036717EDGAR
2023-08-072023-06-300001628280-23-027770EDGAR
2023-05-052023-03-310001628280-23-015990EDGAR
2022-11-032022-09-300000310158-22-000034EDGAR
2022-08-052022-06-300000310158-22-000030EDGAR
2022-05-052022-03-310000310158-22-000011EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-030001104659-26-009495EDGAR9K words
2025-12-040001628280-25-055388EDGAR
2025-10-300001104659-25-103974EDGAR
2025-09-090000310158-25-000047EDGAR
2025-07-290001104659-25-071380EDGAR
2025-05-290001104659-25-054131EDGAR
2025-04-240001104659-25-038301EDGAR
2025-02-040001104659-25-008863EDGAR
2024-11-220001104659-24-122027EDGAR
2024-10-310001104659-24-112841EDGAR

129 total filings indexed. 98 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
MRK Earnings Call Transcript
MRK Earnings Call Transcript
MRK Earnings Call Transcript
MRK Earnings Call Transcript
MRK Earnings Call Transcript
MRK Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology vaccines hospital-acute-care cardiometabolic-and-respiratory virology-/-hiv neuroscience diabetes animal-health---livestock animal-health---companion-animal

Company Identity

CIK0000310158
TickerMRK
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedNJ
Websitehttps://www.merck.com
Listed1949-04-20

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e9730a95437b990365984264d9df5336947720a39fd909be5e9c9aabe6adcec8
parent: f9a9d49d66ef923e2348b5e33be9e89bd08697fb61bc993a99f74ce46df3edda
content hash: fdb0959bc34d598c13c7fa201960f556886b6a5fc5977e1bfd819540a09f6133
signed: 2026-04-13T04:46:21.007Z
sources: 28 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf